Al-Chalabi A, van den Berg LH and Veldink J, ‘Gene Discovery in Amyotrophic Lateral Sclerosis: Implications for Clinical Management’ (2017) 13 Nature Reviews Neurology 96 <https://doi.org/10.1038/nrneurol.2016.182>
Andreasson U, Blennow K and Zetterberg H, ‘Update on Ultrasensitive Technologies to Facilitate Research on Blood Biomarkers for Central Nervous System Disorders’ (2016) 3 Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring 98 <https://doi.org/10.1016/j.dadm.2016.05.005>
Badders NM and others, ‘Selective Modulation of the Androgen Receptor AF2 Domain Rescues Degeneration in Spinal Bulbar Muscular Atrophy’ (2018) 24 Nature Medicine 427 <https://doi.org/10.1038/nm.4500>
Beitel LK and others, ‘Mechanisms Mediating Spinal and Bulbar Muscular Atrophy: Investigations into Polyglutamine-Expanded Androgen Receptor Function and Dysfunction’ (2013) 4 Frontiers in Neurology <https://doi.org/10.3389/fneur.2013.00053>
Belaya K and others, ‘Mutations in Cause Congenital Myasthenic Syndrome and Bridge Myasthenic Disorders with Dystroglycanopathies’ (2015) 138 Brain 2493 <https://doi.org/10.1093/brain/awv185>
Benatar M and others, ‘ALS Biomarkers for Therapy Development: State of the Field and Future Directions’ (2016) 53 Muscle & Nerve 169 <https://doi.org/10.1002/mus.24979>
Berlowitz DJ and others, ‘Identifying Who Will Benefit from Non-Invasive Ventilation in Amyotrophic Lateral Sclerosis/Motor Neurone Disease in a Clinical Cohort’ (2016) 87 Journal of Neurology, Neurosurgery & Psychiatry 280 <https://doi.org/10.1136/jnnp-2014-310055>
Birnkrant DJ and others, ‘Diagnosis and Management of Duchenne Muscular Dystrophy, Part 1: Diagnosis, and Neuromuscular, Rehabilitation, Endocrine, and Gastrointestinal and Nutritional Management’ (2018) 17 The Lancet Neurology 251 <https://doi.org/10.1016/S1474-4422(18)30024-3>
——, ‘Diagnosis and Management of Duchenne Muscular Dystrophy, Part 2: Respiratory, Cardiac, Bone Health, and Orthopaedic Management’ (2018) 17 The Lancet Neurology 347 <https://doi.org/10.1016/S1474-4422(18)30025-5>
——, ‘Diagnosis and Management of Duchenne Muscular Dystrophy, Part 3: Primary Care, Emergency Management, Psychosocial Care, and Transitions of Care across the Lifespan’ (2018) 17 The Lancet Neurology 445 <https://doi.org/10.1016/S1474-4422(18)30026-7>
Bonanomi D and Pfaff SL, ‘Motor Axon Pathfinding’ (2010) 2 Cold Spring Harbor Perspectives in Biology a001735 <https://doi.org/10.1101/cshperspect.a001735>
Brownstone RM and Bui TV, ‘Spinal Interneurons Providing Input to the Final Common Path during Locomotion’ Breathe, Walk and Chew: The Neural Challenge: Part I, vol 187 (Elsevier 2010) <https://doi.org/10.1016/B978-0-444-53613-6.00006-X>
Carrì MT, D’Ambrosi N and Cozzolino M, ‘Pathways to Mitochondrial Dysfunction in ALS Pathogenesis’ (2017) 483 Biochemical and Biophysical Research Communications 1187 <https://doi.org/10.1016/j.bbrc.2016.07.055>
Cortes CJ and others, ‘Muscle Expression of Mutant Androgen Receptor Accounts for Systemic and Motor Neuron Disease Phenotypes in Spinal and Bulbar Muscular Atrophy’ (2014) 82 Neuron 295 <https://doi.org/10.1016/j.neuron.2014.03.001>
Couratier P and others, ‘Epidemiology of Amyotrophic Lateral Sclerosis: A Review of Literature’ (2016) 172 Revue Neurologique 37 <https://doi.org/10.1016/j.neurol.2015.11.002>
Crisp SJ, Kullmann DM and Vincent A, ‘Autoimmune Synaptopathies’ (2016) 17 Nature Reviews Neuroscience 103 <https://doi.org/10.1038/nrn.2015.27>
——, ‘Autoimmune Synaptopathies’ (2016) 17 Nature Reviews Neuroscience 103 <https://doi.org/10.1038/nrn.2015.27>
Cruz PMR, Palace J and Beeson D, ‘Congenital Myasthenic Syndromes and the Neuromuscular Junction’ (2014) 27 Current Opinion in Neurology 566 <https://doi.org/10.1097/WCO.0000000000000134>
Darabid H, Perez-Gonzalez AP and Robitaille R, ‘Neuromuscular Synaptogenesis: Coordinating Partners with Multiple Functions’ (2014) 15 Nature Reviews Neuroscience 703 <https://doi.org/10.1038/nrn3821>
Dasen JS and Jessell TM, ‘Chapter Six Hox Networks and the Origins of Motor Neuron Diversity’ Hox Genes, vol 88 (Elsevier 2009) <https://doi.org/10.1016/S0070-2153(09)88006-X>
Drory VE and others, ‘The Value of Muscle Exercise in Patients with Amyotrophic Lateral Sclerosis’ (2001) 191 Journal of the Neurological Sciences 133 <https://doi.org/10.1016/S0022-510X(01)00610-4>
Engel AG and others, ‘Congenital Myasthenic Syndromes: Pathogenesis, Diagnosis, and Treatment’ (2015) 14 The Lancet Neurology 420 <https://doi.org/10.1016/S1474-4422(14)70201-7>
Finkel RS and others, ‘Diagnosis and Management of Spinal Muscular Atrophy: Part 2: Pulmonary and Acute Care; Medications, Supplements and Immunizations; Other Organ Systems; and Ethics’ (2018) 28 Neuromuscular Disorders 197 <https://doi.org/10.1016/j.nmd.2017.11.004>
Fratta P and others, ‘Correlation of Clinical and Molecular Features in Spinal Bulbar Muscular Atrophy’ (2014) 82 Neurology 2077 <https://doi.org/10.1212/WNL.0000000000000507>
Fuller G and Manford M, Neurology: An Illustrated Colour Text (3rd ed, Churchill Livingstone Elsevier 2010) <http://ucl.alma.exlibrisgroup.com/view/action/uresolver.do?operation=resolveService&package_service_id=3669595080004761&institutionId=4761&customerId=4760>
Gendron TF and others, ‘Poly(GP) Proteins Are a Useful Pharmacodynamic Marker for -Associated Amyotrophic Lateral Sclerosis’ (2017) 9 Science Translational Medicine <https://doi.org/10.1126/scitranslmed.aai7866>
Gibson S and Haringer V, ‘Amyotrophic Lateral Sclerosis: Clinical Perspectives’ [2015] Orphan Drugs: Research and Reviews <https://doi.org/10.2147/ODRR.S63585>
Gilhus NE, ‘Myasthenia Gravis’ (2016) 375 New England Journal of Medicine 2570 <https://doi.org/10.1056/NEJMra1602678>
Gordon E, Rohrer JD and Fox NC, ‘Advances in Neuroimaging in Frontotemporal Dementia’ (2016) 138 Journal of Neurochemistry 193 <https://doi.org/10.1111/jnc.13656>
Harland R, ‘Neural Induction’ (2000) 10 Current Opinion in Genetics & Development 357 <https://doi.org/10.1016/S0959-437X(00)00096-4>
Harwood CA, McDermott CJ and Shaw PJ, ‘Clinical Aspects of Motor Neurone Disease’ (2012) 40 Medicine 540 <https://doi.org/10.1016/j.mpmed.2012.07.003>
Hughes J and others, ‘Principles of Early Drug Discovery’ (2011) 162 British Journal of Pharmacology 1239 <https://doi.org/10.1111/j.1476-5381.2010.01127.x>
Jacobson L and others, ‘Plasma from Human Mothers of Fetuses with Severe Arthrogryposis Multiplex Congenita Causes Deformities in Mice’ (1999) 103 Journal of Clinical Investigation 1031 <https://doi.org/10.1172/JCI5943>
Jessell TM, ‘Neuronal Specification in the Spinal Cord: Inductive Signals and Transcriptional Codes’ (2000) 1 Nature Reviews Genetics 20 <https://doi.org/10.1038/35049541>
Jones RA and others, ‘Cellular and Molecular Anatomy of the Human Neuromuscular Junction’ (2017) 21 Cell Reports 2348 <https://doi.org/10.1016/j.celrep.2017.11.008>
Kanning KC, Kaplan A and Henderson CE, ‘Motor Neuron Diversity in Development and Disease’ (2010) 33 Annual Review of Neuroscience 409 <https://doi.org/10.1146/annurev.neuro.051508.135722>
Koneczny I and others, ‘MuSK Myasthenia Gravis IgG4 Disrupts the Interaction of LRP4 with MuSK but Both IgG4 and IgG1-3 Can Disperse Preformed Agrin-Independent AChR Clusters’ (2013) 8 PLoS ONE <https://doi.org/10.1371/journal.pone.0080695>
Koneczny I, Cossins J and Vincent A, ‘The Role of Muscle-Specific Tyrosine Kinase (MuSK) and Mystery of MuSK Myasthenia Gravis’ (2014) 224 Journal of Anatomy 29 <https://doi.org/10.1111/joa.12034>
Kusner LL and Kaminski HJ, ‘Myasthenia Gravis’ Neurobiology of Brain Disorders (Elsevier 2015) <https://doi.org/10.1016/B978-0-12-398270-4.00010-0>
Ladle DR, Pecho-Vrieseling E and Arber S, ‘Assembly of Motor Circuits in the Spinal Cord: Driven to Function by Genetic and Experience-Dependent Mechanisms’ (2007) 56 Neuron 270 <https://doi.org/10.1016/j.neuron.2007.09.026>
Laurá M and others, ‘Prevalence and Orthopedic Management of Foot and Ankle Deformities in Charcot-Marie-Tooth Disease’ (2018) 57 Muscle & Nerve 255 <https://doi.org/10.1002/mus.25724>
Leung DG, Other Proven and Putative Autoimmune Disorders of the Peripheral Nervous System, vol 1 (Oxford University Press 2017) <https://doi.org/10.1093/med/9780199937837.003.0098>
Li L, Xiong W-C and Mei L, ‘Neuromuscular Junction Formation, Aging, and Disorders’ (2018) 80 Annual Review of Physiology 159 <https://doi.org/10.1146/annurev-physiol-022516-034255>
Lieberman AP and others, ‘Peripheral Androgen Receptor Gene Suppression Rescues Disease in Mouse Models of Spinal and Bulbar Muscular Atrophy’ (2014) 7 Cell Reports 774 <https://doi.org/10.1016/j.celrep.2014.02.008>
Lin G, Mao D and Bellen HJ, ‘Amyotrophic Lateral Sclerosis Pathogenesis Converges on Defects in Protein Homeostasis Associated with TDP-43 Mislocalization and Proteasome-Mediated Degradation Overload’ Fly Models of Human Diseases, vol 121 (Elsevier 2017) <https://doi.org/10.1016/bs.ctdb.2016.07.004>
Lu C-H and others, ‘Neurofilament Light Chain: A Prognostic Biomarker in Amyotrophic Lateral Sclerosis’ (2015) 84 Neurology 2247 <https://doi.org/10.1212/WNL.0000000000001642>
Malik B and others, ‘Absence of Disturbed Axonal Transport in Spinal and Bulbar Muscular Atrophy’ (2011) 20 Human Molecular Genetics 1776 <https://doi.org/10.1093/hmg/ddr061>
Malik B and others, ‘Co-Induction of the Heat Shock Response Ameliorates Disease Progression in a Mouse Model of Human Spinal and Bulbar Muscular Atrophy: Implications for Therapy’ (2013) 136 Brain 926 <https://doi.org/10.1093/brain/aws343>
Manzano R and others, ‘Beyond Motor Neurons: Expanding the Clinical Spectrum in Kennedy’s Disease’ (2018) 89 Journal of Neurology, Neurosurgery & Psychiatry 808 <https://doi.org/10.1136/jnnp-2017-316961>
Maragakis NJ, ‘What Can We Learn from the Edaravone Development Program for ALS?’ (2017) 18 Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 98 <https://doi.org/10.1080/21678421.2017.1361446>
Mazzone ES and others, ‘Revised Upper Limb Module for Spinal Muscular Atrophy: Development of a New Module’ (2017) 55 Muscle & Nerve 869 <https://doi.org/10.1002/mus.25430>
Mercuri E and others, ‘Diagnosis and Management of Spinal Muscular Atrophy: Part 1: Recommendations for Diagnosis, Rehabilitation, Orthopedic and Nutritional Care’ (2018) 28 Neuromuscular Disorders 103 <https://doi.org/10.1016/j.nmd.2017.11.005>
Meriggioli MN and Sanders DB, ‘Autoimmune Myasthenia Gravis: Emerging Clinical and Biological Heterogeneity’ (2009) 8 The Lancet Neurology 475 <https://doi.org/10.1016/S1474-4422(09)70063-8>
Milioto C and others, ‘Beta-Agonist Stimulation Ameliorates the Phenotype of Spinal and Bulbar Muscular Atrophy Mice and Patient-Derived Myotubes’ (2017) 7 Scientific Reports <https://doi.org/10.1038/srep41046>
Mitsumoto H, Brooks BR and Silani V, ‘Clinical Trials in Amyotrophic Lateral Sclerosis: Why so Many Negative Trials and How Can Trials Be Improved?’ (2014) 13 The Lancet Neurology 1127 <https://doi.org/10.1016/S1474-4422(14)70129-2>
Monahan Z, Shewmaker F and Pandey UB, ‘Stress Granules at the Intersection of Autophagy and ALS’ (2016) 1649 Brain Research 189 <https://doi.org/10.1016/j.brainres.2016.05.022>
Morgan S and Orrell RW, ‘Pathogenesis of Amyotrophic Lateral Sclerosis’ (2016) 119 British Medical Bulletin 87 <https://doi.org/10.1093/bmb/ldw026>
Morren JA and Galvez-Jimenez N, ‘Current and Prospective Disease-Modifying Therapies for Amyotrophic Lateral Sclerosis’ (2012) 21 Expert Opinion on Investigational Drugs 297 <https://doi.org/10.1517/13543784.2012.657303>
‘Motor Neurone Disease: Assessment and Management | Guidance and Guidelines | NICE’ <https://www.nice.org.uk/guidance/ng42>
Nishimune H and others, ‘Laminins Promote Postsynaptic Maturation by an Autocrine Mechanism at the Neuromuscular Junction’ (2008) 182 The Journal of Cell Biology 1201 <https://doi.org/10.1083/jcb.200805095>
O’Connor E and others, ‘Clinical and Research Strategies for Limb-Girdle Congenital Myasthenic Syndromes’ (2018) 1412 Annals of the New York Academy of Sciences 102 <https://doi.org/10.1111/nyas.13520>
Orrell, Richard WBarclay, Chris, ‘Diagnosis and Management of Motor Neurone Disease’ 260 Practitioner 17 <https://search.proquest.com/docview/1844334383/64C39DCAF3D346C0PQ/1?accountid=14511>
Otto M and others, ‘Roadmap and Standard Operating Procedures for Biobanking and Discovery of Neurochemical Markers in ALS’ (2012) 13 Amyotrophic Lateral Sclerosis 1 <https://doi.org/10.3109/17482968.2011.627589>
Peragallo JH, ‘Pediatric Myasthenia Gravis’ (2017) 24 Seminars in Pediatric Neurology 116 <https://doi.org/10.1016/j.spen.2017.04.003>
Ramdharry GM and others, ‘A Pilot Study of Proximal Strength Training in Charcot-Marie-Tooth Disease’ (2014) 19 Journal of the Peripheral Nervous System 328 <https://doi.org/10.1111/jns.12100>
Ramsey D and others, ‘Revised Hammersmith Scale for Spinal Muscular Atrophy: A SMA Specific Clinical Outcome Assessment Tool’ (2017) 12 PLOS ONE <https://doi.org/10.1371/journal.pone.0172346>
Reilly MM and others, ‘221st ENMC International Workshop’: (2017) 27 Neuromuscular Disorders 1138 <https://doi.org/10.1016/j.nmd.2017.09.005>
Renton AE, Chiò A and Traynor BJ, ‘State of Play in Amyotrophic Lateral Sclerosis Genetics’ (2014) 17 Nature Neuroscience 17 <https://doi.org/10.1038/nn.3584>
Rodríguez Cruz PM and others, ‘Congenital Myopathies with Secondary Neuromuscular Transmission Defects; A Case Report and Review of the Literature’ (2014) 24 Neuromuscular Disorders 1103 <https://doi.org/10.1016/j.nmd.2014.07.005>
Rodríguez Cruz PM, Palace J and Beeson D, ‘Inherited Disorders of the Neuromuscular Junction: An Update’ (2014) 261 Journal of Neurology 2234 <https://doi.org/10.1007/s00415-014-7520-7>
Rudolf R and others, ‘Degeneration of Neuromuscular Junction in Age and Dystrophy’ (2014) 6 Frontiers in Aging Neuroscience <https://doi.org/10.3389/fnagi.2014.00099>
Ruegsegger C and Saxena S, ‘Proteostasis Impairment in ALS’ (2016) 1648 Brain Research 571 <https://doi.org/10.1016/j.brainres.2016.03.032>
Scoto M and others, ‘Therapeutic Approaches for Spinal Muscular Atrophy (SMA)’ (2017) 24 Gene Therapy 514 <https://doi.org/10.1038/gt.2017.45>
Singhal N and Martin PT, ‘Role of Extracellular Matrix Proteins and Their Receptors in the Development of the Vertebrate Neuromuscular Junction’ (2011) 71 Developmental Neurobiology 982 <https://doi.org/10.1002/dneu.20953>
Spillane J and others, ‘Lambert-Eaton Syndrome IgG Inhibits Transmitter Release via P/Q Ca2+ Channels’ (2015) 84 Neurology 575 <https://doi.org/10.1212/WNL.0000000000001225>
Spillane J, Beeson DJ and Kullmann DM, ‘Myasthenia and Related Disorders of the Neuromuscular Junction’ (2010) 81 Journal of Neurology, Neurosurgery & Psychiatry 850 <https://doi.org/10.1136/jnnp.2008.169367>
Viegas S and others, ‘Passive and Active Immunization Models of MuSK-Ab Positive Myasthenia: Electrophysiological Evidence for Pre and Postsynaptic Defects’ (2012) 234 Experimental Neurology 506 <https://doi.org/10.1016/j.expneurol.2012.01.025>
Vincent A, ‘Unravelling the Pathogenesis of Myasthenia Gravis’ (2002) 2 Nature Reviews Immunology 797 <https://doi.org/10.1038/nri916>
‘Volume 58, Issue 3, March 2016’ Volume 58, Issue 3, March 2016 <https://link.springer.com/journal/12031/58/3>
Westerberg E and others, ‘The Impact of Physical Exercise on Neuromuscular Function in Myasthenia Gravis Patients’ (2018) 97 Medicine <https://doi.org/10.1097/MD.0000000000011510>
Wolfe GI and others, ‘Randomized Trial of Thymectomy in Myasthenia Gravis’ (2016) 375 New England Journal of Medicine 511 <https://doi.org/10.1056/NEJMoa1602489>
Woollacott IOC and Rohrer JD, ‘The Clinical Spectrum of Sporadic and Familial Forms of Frontotemporal Dementia’ (2016) 138 Journal of Neurochemistry 6 <https://doi.org/10.1111/jnc.13654>
